QURENasdaqPharmaceutical PreparationsFiscal year ends December 31
uniQure N.V.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$22.20+0.42 (+1.93%)
Close on Oct 19, 2026
- Market cap
- $1.47B
- P/E (TTM)
- –
- Dividend yield
- –
uniQure statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | uniQure | Industry median |
|---|---|---|
| Market Cap | $1.54B | $166.30M |
| Enterprise Value | $1.18B | $88.19M |
| PS Ratio | 82.47 | 3.65 |
| PB Ratio | 4.75 | 2.03 |
| P/TBV Ratio | 6.49 | 2.29 |
Enterprise value
| Measure | uniQure | Industry median |
|---|---|---|
| EV / Sales | 63.04 | 2.51 |
Income (trailing twelve months)
| Measure | uniQure | Industry median |
|---|---|---|
| Revenue | $18.67M | $58.34M |
| Gross Profit | $17.27M | $105.94M |
| Operating Income | -$200.08M | -$21.40M |
| Pretax Income | -$245.17M | -$14.34M |
| Net Income | -$252.21M | -$22.46M |
| EBITDA | -$185.61M | -$16.91M |
| EPS (Diluted) | -$4.04 | -$0.83 |
Margins
| Measure | uniQure | Industry median |
|---|---|---|
| Gross Margin | 92.5% | 52.9% |
| Operating Margin | -1071.5% | -44.0% |
| Pretax Margin | -1313.0% | -13.3% |
| Profit Margin | -1350.7% | -40.2% |
| EBITDA Margin | -994.1% | -30.2% |
| FCF Margin | -864.7% | -9.27% |
Returns
| Measure | uniQure | Industry median |
|---|---|---|
| Return on Equity (ROE) | -157.6% | -53.2% |
| Return on Assets (ROA) | -32.1% | -40.9% |
| Return on Capital Employed (ROCE) | -22.2% | -38.1% |
Growth
| Measure | uniQure | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 30.2% | 5.96% |
| Revenue Growth (3Y CAGR) | -46.7% | 2.25% |
| Revenue Growth (5Y CAGR) | -15.6% | 6.48% |
Balance sheet
| Measure | uniQure | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $413.03M | $61.43M |
| Total Debt | $50.15M | $118.52M |
| Net Cash (Debt) | $362.88M | $15.35M |
| Net Cash Per Share | $5.23 | $0.66 |
| Equity (Book Value) | $324.05M | $49.09M |
| Book Value Per Share | $4.67 | $1.37 |
| Tangible Book Value | $237.36M | $23.52M |
| Working Capital | $750.92M | $76.81M |
Financial position
| Measure | uniQure | Industry median |
|---|---|---|
| Current Ratio | 10.01 | 3.34 |
| Quick Ratio | 5.02 | 2.44 |
| Debt / Equity | 0.15 | 0.52 |
| Interest Coverage | -3.35 | -6.26 |
Cash flow (trailing twelve months)
| Measure | uniQure | Industry median |
|---|---|---|
| Operating Cash Flow | -$160.79M | -$12.35M |
| Capital Expenditures | -$665.00K | -$1.08M |
| Free Cash Flow | -$161.45M | -$20.22M |
| FCF Per Share | -$2.33 | -$0.42 |
Efficiency
| Measure | uniQure | Industry median |
|---|---|---|
| Asset Turnover | 0.02 | 0.39 |
| Revenue Per Employee | $84.49K | $404.87K |
| Profits Per Employee | -$1.14M | -$703.34K |
| Employee Count | 221 | 74 |
Dividends and yields
| Measure | uniQure | Industry median |
|---|---|---|
| Earnings Yield | -16.4% | -23.3% |
| FCF Yield | -10.5% | -8.72% |
Shares
| Measure | uniQure | Industry median |
|---|---|---|
| Shares Outstanding | 69,366,400 | 58,127,000 |
| Shares Change (YoY) | 21.6% | 10.9% |
| Shares Change (QoQ) | 10.00% | 0.54% |
| Float | 67,909,000 | 49,136,700 |
| Shares Held by Insiders | 2.10% | 11.6% |
Taxes
| Measure | uniQure | Industry median |
|---|---|---|
| Income Tax | $7.04M | $79.87K |
Scores
| Measure | uniQure | Industry median |
|---|---|---|
| Altman Z-Score | -0.42 | -0.22 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from uniQure's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.